Talphera Inc (TLPH) Stock Price, Quote & News

Company Profile

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral,...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 650 216 3500

Website: talphera.com

Address:

1850 Gateway Drive, Suite 175, San Mateo, United States

bobmoney Sep. 9 at 5:18 PM

$TLPH yep, at the end of what will likely be a succeasful Phase 3 trial... CRMD has the 1st right to negotiate the purchase of Niyad... !!

0 · Reply

bobmoney Sep. 9 at 4:12 PM

$TLPH Total Volume this week, & counting: -- 74 million shares... -- !!

0 · Reply

Crandaddy01 Sep. 9 at 3:11 PM

$TLPH stock-twitter watchers are slowly growing :)

0 · Reply

Nakuldesai Sep. 9 at 2:51 PM

$TLPH lets zoom past 1.

0 · Reply

algo888 Sep. 9 at 2:48 PM

$TLPH sellers @ .96 HOD lol

0 · Reply

algo888 Sep. 9 at 2:38 PM

$TLPH .92 Push it... 2 of my explosive plays >> $EQ

0 · Reply

GluttonBoy Sep. 9 at 2:17 PM

TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $MSS $IMG $TLPH $DUO $XAIR looking good

0 · Reply

nazzangr Sep. 9 at 2:09 PM

$TLPH tomorrow is dilution day peeps. watch out

1 · Reply

algo888 Sep. 9 at 2:00 PM

$TLPH price upon 1.00 re-entry

0 · Reply

indybucfan Sep. 9 at 1:47 PM

$TLPH

0 · Reply

CorMedix Announces Strategic Minority Investment in Talphera

CRMD

Sep 8, 2025, 8:30 AM EDT - 1 day ago

Talphera Announces Private Placement Financing of up to $29 Million Priced At-the Market

CRMD

Aug 25, 2025, 8:30 AM EDT - 15 days ago

Talphera Announces Achievement of 17 Patient Enrollment Milestone in NEPHRO CRRT Pivotal Trial

Aug 14, 2025, 9:10 PM EDT - 25 days ago

Talphera, Inc. (TLPH) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:05 PM EDT - 25 days ago

Talphera Announces Second Quarter 2025 Financial Results and Provides Corporate Update

Aug 7, 2025, 4:35 PM EDT - 4 weeks ago

Talphera to Host Second Quarter Financial Results and Corporate Update Call and Webcast on Thursday, August 14, 2025

May 14, 2025, 9:01 PM EDT - 4 months ago

Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 4 months ago

Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update

May 7, 2025, 4:05 PM EDT - 4 months ago

Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025

Mar 31, 2025, 6:33 PM EDT - 5 months ago

Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:05 PM EDT - 5 months ago

Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 31, 2025, 8:30 AM EDT - 5 months ago

Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million

Mar 26, 2025, 4:38 PM EDT - 5 months ago

Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025

Jan 14, 2025, 8:30 AM EST - 8 months ago

Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study

Nov 13, 2024, 6:43 PM EST - 10 months ago

Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 10 months ago

Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 6, 2024, 4:05 PM EST - 10 months ago

Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024

Oct 8, 2024, 4:54 PM EDT - 11 months ago

Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Sep 5, 2024, 4:15 PM EDT - 1 year ago

Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 19, 2024, 8:30 AM EDT - 1 year ago

Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit

Aug 14, 2024, 6:39 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Talphera Announces Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 5, 2024, 4:05 PM EDT - 1 year ago

Talphera to Host Second Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, August 14, 2024

May 20, 2024, 5:25 PM EDT - 1 year ago

Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 16, 2024, 5:45 PM EDT - 1 year ago

Talphera to Participate at A.G.P. Virtual Healthcare Conference

May 14, 2024, 6:21 PM EDT - 1 year ago

Talphera, Inc. (TLPH) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

Talphera Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 2, 2024, 4:15 PM EDT - 1 year ago

Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024

Mar 6, 2024, 9:48 PM EST - 1 year ago

Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript

Mar 6, 2024, 4:05 PM EST - 1 year ago

Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update

Mar 1, 2024, 7:30 AM EST - 1 year ago

Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members

Feb 26, 2024, 4:15 PM EST - 1 year ago

Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024

Jan 18, 2024, 8:30 AM EST - 1 year ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

bobmoney Sep. 9 at 5:18 PM

$TLPH yep, at the end of what will likely be a succeasful Phase 3 trial... CRMD has the 1st right to negotiate the purchase of Niyad... !!

0 · Reply

bobmoney Sep. 9 at 4:12 PM

$TLPH Total Volume this week, & counting: -- 74 million shares... -- !!

0 · Reply

Crandaddy01 Sep. 9 at 3:11 PM

$TLPH stock-twitter watchers are slowly growing :)

0 · Reply

Nakuldesai Sep. 9 at 2:51 PM

$TLPH lets zoom past 1.

0 · Reply

algo888 Sep. 9 at 2:48 PM

$TLPH sellers @ .96 HOD lol

0 · Reply

algo888 Sep. 9 at 2:38 PM

$TLPH .92 Push it... 2 of my explosive plays >> $EQ

0 · Reply

GluttonBoy Sep. 9 at 2:17 PM

TAIT stock is at zero borrow with shorts trapped and about to have a historic squeeze 3M float with no dilution and is a profitable semiconductor play $MSS $IMG $TLPH $DUO $XAIR looking good

0 · Reply

nazzangr Sep. 9 at 2:09 PM

$TLPH tomorrow is dilution day peeps. watch out

1 · Reply

algo888 Sep. 9 at 2:00 PM

$TLPH price upon 1.00 re-entry

0 · Reply

indybucfan Sep. 9 at 1:47 PM

$TLPH

0 · Reply

algo888 Sep. 9 at 12:56 PM

$TLPH hope scumbags loaded that dip again @ .68

1 · Reply

NextRunnerTV Sep. 9 at 10:25 AM

NEW VIDEO ON TICKER ＄MSS , once this breaks $1.60 it can see $2.2/3.00 fast‼️ https://www.tiktok.com/@nextrunnertv/video/7547827510671674679 $OCTO $SNTG $XAIR $TLPH

0 · Reply

stevenryl86 Sep. 9 at 9:38 AM

$TLPH 0.55 or lower ?

1 · Reply

HT2018 Sep. 9 at 9:10 AM

$TLPH what's the guess on buyout

0 · Reply

bobmoney Sep. 9 at 5:14 AM

$TLPH if Talphera gets Niyad FDA approved (bidding war please...) then... LTX-608 Phase 2 ready... some high potential indications... Don't forget!

0 · Reply

Nakuldesai Sep. 9 at 4:25 AM

$TLPH green overnight.

0 · Reply

StockScanners Sep. 9 at 3:56 AM

$TLPH keep watch if this holds above .78

0 · Reply

BearTamerTrading Sep. 9 at 2:49 AM

🔥 What a magnificent live trading stream today! Right at 6 AM, I called out $HOUR for the continuation play. Shortly after, I flagged $OCTO—and once the catalyst dropped, we started buying in the low $3S. Final sell? $56. Absolute monster move. 🚀 I also made a solid move on $XAIR, which worked out beautifully, and $TLPH, which not only paid today but I still consider a strong swing trade setup. 🎯 Big shoutout to Alex Holmes for calling out $SKYQ—that one gave us some amazing gains too. 💯 Don’t just take my word for it—watch the stream from today below 👇🏾 👉 https://www.youtube.com/live/teT1szsEo54?si=ztqZjtltnFVWqGSb Catch you guys tomorrow morning at 6 AM sharp for the next session. Stop missing out !

0 · Reply

stevenryl86 Sep. 9 at 1:56 AM

$TLPH ok it seems they have sufficient funding given the recent CRMD investment and to fund TLPH until Phase 3. Now the question, can they maintain min bid 1.00. I don’t want any RS

0 · Reply

stevenryl86 Sep. 9 at 1:06 AM

$TLPH can they hit min bid 1.0 without going for RS? Noted on their cash, do they need to raise cash? I’m looking to buy some share but have the above 2 concern

0 · Reply

algo888 Sep. 8 at 11:37 PM

$TLPH 1 million got in 1 Hr towards the closing...

0 · Reply

Noname2022 Sep. 8 at 11:13 PM

$CRMD $TLPH

6 · Reply

Market Cap	11.27M
Revenue (ttm)	0.00
Net Income (ttm)	-13.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	2,388,656
Avg Vol	3,179,432
Day's Range	N/A - N/A
Shares Out	20.52M
Stochastic %K	56%
Beta	-0.16
Analysts	Strong Sell
Price Target	$3.25